Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about TKPHF
Recent news which mentions TKPHF
Takeda Moves Out From Licensing Agreement With Theravance Biopharma
May 11, 2023
Tickers
TAK
TBPH
TKPHF
Tags
News
Small Cap
General
From
Benzinga
Takeda's FY22 Net Profit Jumps 38%, But Expects Lower FY23 Revenues
May 11, 2023
Tickers
TAK
TKPHF
Tags
TKPHF
Pre/Market Outlook
Biotech
From
Benzinga
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
April 21, 2023
Tickers
GSK
MRK
SNY
TAK
Tags
Media
News
Market News
From
Benzinga
Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says
March 20, 2023
Tickers
BMY
TAK
TKPHF
Tags
Analyst Ratings
Analyst Color
Biotech
From
Benzinga
Takeda Presents Vedolizumab Data For Preventing Graft-Versus-Host Disease In Stem Cell Transplant Patients
February 21, 2023
Tickers
TAK
TKPHF
Tags
TAK
Benzinga
Market News
From
Benzinga
Takeda Reports 13% Fall In Nine Month Operating Profit, Keeps Annual Guidance Unchanged
February 02, 2023
Tickers
TAK
TKPHF
Tags
Guidance
News
Briefs
From
Benzinga
Why Shares of Phathom Pharmaceutical Jumped This Week
January 28, 2023
Tickers
PHAT
TKPHF
Tags
Recent Press Releases
Market News
PHAT
From
Motley Fool
Arrowhead Pharmaceuticals Reports Underwhelming Data From Inherited Disease Study
January 09, 2023
Tickers
ARWR
TAK
TKPHF
Tags
Movers
Market News
General
From
Benzinga
Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B
December 13, 2022
Tickers
TAK
TKPHF
Tags
Briefs
General
Large Cap
From
Benzinga
Takeda's Dengue Vaccine Candidate Under FDA Priority Review
November 23, 2022
Tickers
TAK
TKPHF
Tags
News
TKPHF
Benzinga
From
Benzinga
Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings
November 17, 2022
Tickers
PBYI
TAK
TKPHF
Tags
News
TKPHF
Biotech
From
Benzinga
Takeda Posts Lower 1H Profit, Lifts FY22 Outlook
October 27, 2022
Tickers
TAK
TKPHF
Tags
TKPHF
Earnings
Biotech
From
Benzinga
Takeda Seeks FDA Approval For Hereditary Angioedema Treatment For Younger Kids
October 05, 2022
Tickers
TAK
TKPHF
Tags
Biotech
TKPHF
News
From
Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
August 30, 2022
Tickers
GSK
MRK
SNY
TAK
Tags
TKPHF
News
Biotech
From
Benzinga
After Six Years Of Collaboration, Takeda Walks Away From Microbiome Drug Pact
August 26, 2022
Tickers
FNCH
TAK
TKPHF
Tags
FNCH
Biotech
News
From
Benzinga
EXCLUSIVE: Takeda's Cancer Partner BridGene Raises $38.5M To Accelerate Work On Undruggable Targets
July 27, 2022
Tickers
TAK
TKPHF
Tags
TKPHF
News
Biotech
From
Benzinga
Takeda Touts Encouraging Data For Hyqvia In Rare Nerve Inflammation Disorder
July 21, 2022
Tickers
TAK
TKPHF
Tags
TAK
Benzinga
Large Cap
From
Benzinga
Takeda's Hereditary Angioedema Treatment Prevents Attacks In Kids Below 12 Years
July 01, 2022
Tickers
TAK
TKPHF
Tags
Biotech
News
TKPHF
From
Benzinga
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
May 17, 2022
Tickers
BMY
ETSY
EXEL
IPSEY
Tags
TKPHF
EXEL
BMY
From
Motley Fool
Takeda Pharma Clocks 1% Increase In FY21 Core Profit, Expects Growth Momentum In FY22
May 11, 2022
Tickers
TAK
TKPHF
Tags
Benzinga
TAK
Health Care
From
Benzinga
Takeda's Maribavir Reduces Hospitalization Rates, Hospital Stay In Post-Transplant Infection Patients
April 22, 2022
Tickers
TAK
TKPHF
Tags
Health Care
General
Briefs
From
Benzinga
Takeda's Angioedema Drug Shows Promising Action Against COVID-19 Infection
March 08, 2022
Tickers
TAK
TKPHF
Tags
TAK
Benzinga
COVID/19 Coronavirus
From
Benzinga
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
February 22, 2022
Tickers
AZN
AZNCF
RHHBY
TAK
Tags
Legal
AZN
News
From
Benzinga
Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
February 22, 2022
Tickers
TAK
TKPHF
Tags
Contracts
Benzinga
Market News
From
Benzinga
Real-World Analysis Show Takeda's Alofisel Clinical Remission Rate At Six-Months
February 18, 2022
Tickers
TAK
TKPHF
Tags
Benzinga
Market News
TAK
From
Benzinga
FDA Approves Takeda's Vonvendi As Prophylactic Treatment In Bleeding Disorder
January 31, 2022
Tickers
TAK
TKPHF
Tags
TKPHF
News
Biotech
From
Benzinga
FDA Rejects Takeda's Eosinophilic Esophagitis Candidate, Asks For Additional Study
December 22, 2021
Tickers
TAK
TKPHF
Tags
Health Care
Briefs
General
From
Benzinga
Novavax Files For Approval Of Its COVID-19 Vaccine In Japan
December 16, 2021
Tickers
NVAX
TAK
TKPHF
Tags
Health Care
COVID/19 Vaccine
TAK
From
Benzinga
Takeda's Maribavir Scores FDA Approval For Post-Transplant CMV Infection
November 24, 2021
Tickers
TAK
TKPHF
Tags
Biotech
News
Phase 3 Trial
From
Benzinga
Takeda, Shattuck Labs Terminate Immuno-Oncology Pact
November 09, 2021
Tickers
STTK
TAK
TKPHF
Tags
Health Care
TAK
Benzinga
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.